GW PHARMACEUTICALS LIMITED
Get an alert when GW PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
—
Equity attributable
Employees
—
Average over period
Profit before tax
£671m
USD 903,758,000
+757.9% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£290,242 | -£1,219,357 | £5,195 | +100.4% | |
| Profit before tax | -£445,560 | £78,182,904 | £670,692,393 | +757.9% | |
| Net profit | -£445,560 | £78,182,904 | £677,444,156 | +766.5% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £1,076,393,160 | £993,530,723 | — | — | |
| Net assets | £1,076,393,160 | £993,530,723 | — | — | |
| Equity | £1,076,393,160 | £993,530,723 | — | — | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £688,735 | £474,371 | — | — | |
| Directors' pension contributions | £27,455 | £28,653 | — | — | |
| Highest paid director | £442,422 | £589,780 | — | — |
Figures converted to GBP from USD at 0.742 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | -0.0% | -0.1% | — | |
| Gearing (liabilities / total assets) | 0.4% | 0.3% | — | |
| Current ratio | 0.10x | 0.04x | — | |
| Interest cover | -1.87x | -7.44x | 0.04x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- GW PHARMACEUTICALS LIMITED 2021-06-04 → present
- GW PHARMACEUTICALS PLC 2001-06-01 → 2021-06-04
- GW PHARMACEUTICALS GROUP PLC 2001-03-06 → 2001-06-01
- MAWLAW 541 PLC 2001-02-15 → 2001-03-06
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PATEL, Alkesh | Secretary | 2024-04-03 | — | — |
| FLANAGAN, Amanda | Director | 2025-02-10 | Aug 1971 | Irish |
| SPACKMAN, David James | Director | 2023-01-13 | Jan 1976 | British |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DOODY, Aislinn Jane | Secretary | 2023-01-13 | 2024-04-03 |
| GEORGE, Adam David | Secretary | 2008-03-05 | 2020-12-18 |
| HILLHOUSE, Robert James | Secretary | 2001-02-15 | 2001-05-31 |
| LAUGHTON, Jonathan Michael | Secretary | 2001-05-31 | 2008-03-05 |
| SNYDER, Douglas | Secretary | 2020-12-18 | 2021-08-12 |
| WARD, Iain | Secretary | 2021-08-12 | 2023-01-13 |
| ARMISSOGLIO ÉP. LEPELLETIER, Nelly Alexandra | Director | 2023-01-13 | 2025-02-10 |
| BROWN, Cabot | Director | 2013-02-19 | 2021-05-05 |
| BROWN, Cabot | Director | 2013-01-18 | 2013-01-18 |
| CAMPBELL, Adrian | Director | 2021-05-05 | 2023-01-01 |
| FORREST, Richard George | Director | 2007-03-15 | 2013-01-18 |
| GANGOLLI, Julian Steatham | Director | 2015-07-16 | 2017-02-13 |
| GEORGE, Adam David | Director | 2012-06-01 | 2017-02-13 |
| GOVER, Justin David | Director | 2001-03-05 | 2021-05-05 |
| GRYSKA, David | Director | 2020-09-09 | 2021-05-05 |
| GUY, Geoffrey William, Dr | Director | 2001-03-05 | 2021-05-05 |
| KIRK, David Francis | Director | 2001-09-10 | 2012-06-01 |
| LAUGHTON, Jonathan Michael | Director | 2001-03-05 | 2001-09-10 |
| LYNCH, Thomas Gerard | Director | 2010-07-27 | 2020-04-01 |
| MACE, David Champion | Director | 2001-03-05 | 2007-03-20 |
| MACKEY, Catherine | Director | 2017-12-21 | 2021-05-05 |
| MORRISON, David John | Director | 2006-02-09 | 2007-03-15 |
| MOUNTFORD, Peter | Director | 2001-03-05 | 2006-02-09 |
| NOBLE, James Julian | Director | 2007-01-26 | 2021-05-05 |
| SCHRAM, Hans | Director | 2003-04-16 | 2010-07-27 |
| SECOR, Alicia Mary | Director | 2017-12-21 | 2021-05-05 |
| TOVEY, Christopher John | Director | 2012-10-01 | 2017-02-13 |
| WALDEGRAVE, William Arthur, Lord | Director | 2017-12-21 | 2021-05-05 |
| WARD, Iain Stuart | Director | 2021-05-05 | 2023-01-13 |
| WHITTLE, Brian Anthony | Director | 2001-03-05 | 2008-03-18 |
| WRIGHT, Stephen, Dr | Director | 2005-03-22 | 2017-02-13 |
| MAWLAW ADMINISTRATION LIMITED | Corporate Director | 2001-02-15 | 2001-03-05 |
| MAWLAW CORPORATE SERVICES LIMITED | Corporate Director | 2001-02-15 | 2001-03-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Jazz Pharmaceuticals Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-05-05 | Active |
Filing timeline
Last 20 of 407 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-15 | AA | accounts | Accounts with accounts type full | |
| 2026-07-09 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-07-09 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-02-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-30 | AA | accounts | Accounts with accounts type full | |
| 2025-02-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-12 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-27 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-10-12 | AA | accounts | Accounts with accounts type full | |
| 2024-04-18 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-04-18 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-02-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-23 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-10-26 | AA | accounts | Accounts with accounts type full | |
| 2023-02-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-02-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-02-06 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-02-06 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2023-01-16 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.